Digital Health is the new Health Care. From telemedicine, to patient engagement, to clinical trials, to home care services, nothing in the future of healthcare will be outside the realm of digital health. That said, the landscape of healthcare technology solutions are both vast, complex, and are rarely ever a “plug and play” opportunity. A&M focuses on partnering with your organization, technology firms, and implementation firms to redesign your organization to gain the best business performance tied to the technology that is right for you.
We support HealthTech companies and investors through:
- Technology selection and investment assessment
- Operating model review and target operating model design
- Strategic business and investment planning
- Technology and implementation partnership management
- Change management and program leadership
- Operational KPIs and improvement metrics
- Contract Review and Management
- Interim leadership during transformation
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
The Effect of Trump’s Tariffs on the European Pharmaceutical and Biopharmaceutical Industry
June 9, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could
be felt across the global healthcare landscape.
FORMER FEDERAL HEALTH MINISTER PROFESSOR GREG HUNT JOINS ALVAREZ & MARSAL AUSTRALIA
May 27, 2025
Alvarez & Marsal appoints The Honourable Greg Hunt as a Senior Advisor bolstering its Healthcare and Public Sector advisories in support of maximizing sustainable value for clients.
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
